GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
5,302
Funds Holding Change
-63
Funds Holding Growth
-1%
Value
$1.19T
Holding in Top 10
578
Top 10 Change
-190
Top 10 Growth
-25%
Value Growth
-9%
New
218
Increased
2,481
Reduced
2,225
Closed
207
Capital Inflow
$40.1B
Capital Outflow
$83.2B
Net Capital Flow
-$43.1B
Capital Flow Change
-$95.1B
Calls
$26.4B
Puts
$23.6B
Net Calls
+$2.73B
Put/Call Ratio
0.9